Position in CBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,880,000
-$429,200 QoQ
Shares Held
1,160,000
0.0% QoQ
Ownership
3.12%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#11
of 79 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TANG CAPITAL MANAGEMENT LLC holds $1,792,526,680 across 34 Biotechnology names. CBIO ranks #20 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AUPH |
Aurinia Pharmaceuticals Inc.
|
13,044,106 | $221,358,478 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
1,892,200 | $167,989,516 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,236,027 | $144,701,680 | |
| 4 | CELC |
Celcuity Inc.
|
1,314,594 | $137,532,824 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
1,500,000 | $130,425,000 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
1,500,000 | $122,355,000 | |
| 7 | LKFT |
Lakefront Biotherapeutics NV
|
3,785,991 | $113,504,010 | |
| 8 | CAPR |
Capricor Therapeutics, Inc.
|
4,099,900 | $98,725,592 |
All Filings in CBIO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,880,000 | 1,160,000 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $21,309,200 | 1,160,000 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $21,309,200 | 1,160,000 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $10,346,640 | 872,398 | Shares | Other | 2026-02-17 | |
| 2025-10-02 | $8,421,000 | 700,000 | Shares | Sole | 2025-10-09 | |
| 2025-09-30 | $8,083,107 | 679,824 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $809,453 | 50,152 | Shares | Other | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||